A New Treatment for Primary Smear-positive Pulmonary Tuberculosis With Interleukin-2

Clinical trial NCT04766307 · UNKNOWN

Trial details

NCT number: NCT04766307
Sponsor: Beijing Chest Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Tuberculosis, Pulmonary

Start date: 2016-07-20
Primary completion: 2021-12-31
Enrollment: 1100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.